simendan has been researched along with alprostadil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, R; Bojic, A; Huelsmann, M; Moertl, D; Pacher, R | 1 |
McLachlan, CS; Mossop, P | 1 |
Ahmadi, R; Berger, R; Bojic, A; Heissenberger, I; Huelsmann, M; Moertl, D; Pacher, R | 1 |
2 trial(s) available for simendan and alprostadil
Article | Year |
---|---|
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprostadil; Biomarkers; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Phosphodiesterase Inhibitors; Prospective Studies; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Vasodilator Agents | 2005 |
Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
Topics: Adrenergic beta-Antagonists; Alprostadil; Cardiotonic Agents; Drug Interactions; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Simendan; Stroke Volume; Vasodilator Agents | 2007 |
1 other study(ies) available for simendan and alprostadil
Article | Year |
---|---|
Levosimendan and plasma BNP levels: do inflammatory cytokines regulate BNP in chronic decompensated heart failure?
Topics: Alprostadil; Biomarkers; Cardiotonic Agents; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Stroke Volume; Vasodilator Agents | 2006 |